HOXA13 contributes to gastric carcinogenesis through DHRS2 interacting with MDM2 and confers 5-FU resistance by a p53-dependent pathway
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
HOXA13 contributes to gastric carcinogenesis through DHRS2 interacting with MDM2 and confers 5-FU resistance by a p53-dependent pathway
Authors
Keywords
-
Journal
MOLECULAR CARCINOGENESIS
Volume 57, Issue 6, Pages 722-734
Publisher
Wiley
Online
2018-02-13
DOI
10.1002/mc.22793
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Gastric Cancer, Version 2.2013
- (2017) Jaffer A. Ajani et al. Journal of the National Comprehensive Cancer Network
- HOTTIP and HOXA13 are oncogenes associated with gastric cancer progression
- (2016) SHUAI CHANG et al. ONCOLOGY REPORTS
- Genetic variation of the ABC transporter gene ABCC1 (Multidrug resistance protein 1 – MRP1) in the Polish population
- (2015) Marcin Słomka et al. BMC GENETICS
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- p53 overexpression increases chemosensitivity in multidrug-resistant osteosarcoma cell lines
- (2015) Shunan Ye et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Overexpression of HOXA10 promotes gastric cancer cells proliferation and HOXA10+/CD44+ is potential prognostic biomarker for gastric cancer
- (2015) Yang Han et al. EUROPEAN JOURNAL OF CELL BIOLOGY
- Improving survival by exploiting tumour dependence on stabilized mutant p53 for treatment
- (2015) E. M. Alexandrova et al. NATURE
- Recurrent Glioblastomas Reveal Molecular Subtypes Associated with Mechanistic Implications of Drug-Resistance
- (2015) So Mee Kwon et al. PLoS One
- MDM2-p53 Pathway in Hepatocellular Carcinoma
- (2014) X. Meng et al. CANCER RESEARCH
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Upregulation of Autophagy-Related Gene-5 (ATG-5) Is Associated with Chemoresistance in Human Gastric Cancer
- (2014) Jie Ge et al. PLoS One
- Genomic landscape and genetic heterogeneity in gastric adenocarcinoma revealed by whole-genome sequencing
- (2014) Swee Seong Wong et al. Nature Communications
- Identification and validation that up-expression of HOXA13 is a novel independent prognostic marker of a worse outcome in gastric cancer based on immunohistochemistry
- (2013) Yang Han et al. MEDICAL ONCOLOGY
- Characterization of amplification patterns and target genes on the short arm of chromosome 7 in early-stage lung adenocarcinoma
- (2013) JI UN KANG Molecular Medicine Reports
- The diagnosis and management of gastric cancer
- (2013) S. G. Thrumurthy et al. BMJ-British Medical Journal
- p53-Mediated Senescence Impairs the Apoptotic Response to Chemotherapy and Clinical Outcome in Breast Cancer
- (2012) James G. Jackson et al. CANCER CELL
- Combinatorial drug therapy for cancer in the post-genomic era
- (2012) Bissan Al-Lazikani et al. NATURE BIOTECHNOLOGY
- WNT6 is a novel target gene of caveolin-1 promoting chemoresistance to epirubicin in human gastric cancer cells
- (2012) G Yuan et al. ONCOGENE
- Decreased Expression of RASSF6 Is a Novel Independent Prognostic Marker of a Worse Outcome in Gastric Cancer Patients after Curative Surgery
- (2011) Yugang Wen et al. ANNALS OF SURGICAL ONCOLOGY
- Exploration of target genes of HOXA13 in esophageal squamous cell carcinoma cell line
- (2011) Lu-Yan Shen et al. CANCER LETTERS
- The HOX gene network in hepatocellular carcinoma
- (2011) Clemente Cillo et al. INTERNATIONAL JOURNAL OF CANCER
- Five-Year Outcomes of a Randomized Phase III Trial Comparing Adjuvant Chemotherapy With S-1 Versus Surgery Alone in Stage II or III Gastric Cancer
- (2011) Mitsuru Sasako et al. JOURNAL OF CLINICAL ONCOLOGY
- 14-3-3γ Inhibition of MDMX-mediated p21 Turnover Independent of p53
- (2010) Jun-Ho Lee et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Mitochondrial HEP27 Is a c-Myb Target Gene That Inhibits Mdm2 and Stabilizes p53
- (2010) C. Deisenroth et al. MOLECULAR AND CELLULAR BIOLOGY
- HOX transcription factors are potential therapeutic targets in non-small-cell lung cancer (targeting HOX genes in lung cancer)
- (2009) L Plowright et al. BRITISH JOURNAL OF CANCER
- Small-Molecule Multidrug Resistance-Associated Protein 1 Inhibitor Reversan Increases the Therapeutic Index of Chemotherapy in Mouse Models of Neuroblastoma
- (2009) C. A. Burkhart et al. CANCER RESEARCH
- Locally Advanced and Metastatic Gastric Cancer
- (2008) Kathryn Field et al. DRUGS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started